LMWE:F:F-Lyxor FTSE EPRA/NAREIT Global Developed UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 37.475

Change

-0.37 (-0.98)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.20 (+0.77%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.36 (+0.71%)

USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.15 (+0.71%)

USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.04 (-0.01%)

USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.38 (+0.71%)

USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

-0.23 (-0.26%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.70 (+0.75%)

USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.09 (+0.61%)

USD 56.18B
VUSA:F Vanguard Funds Public Limited ..

+0.02 (+0.02%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.08 (-0.09%)

USD 49.95B

ETFs Containing LMWE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.15% 16% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.15% 15% F 34% F
Trailing 12 Months  
Capital Gain -1.45% 32% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.45% 30% F 47% F
Trailing 5 Years  
Capital Gain -18.12% 8% B- 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.12% 8% B- 22% F
Average Annual (5 Year Horizon)  
Capital Gain -3.03% 26% F 37% F
Dividend Return -3.03% 26% F 34% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.14% 24% F 58% F
Risk Adjusted Return -15.81% 38% F 39% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.